Mark Cuban on High Drug Prices, Taxing Billionaires, and 2028

Mark Cuban has been pestered online for years about buying the domain GoBlue.com. He finally gave in at $38,000, redirected it to Indiana University's NIL page as a rivalry joke, and then got a cease-and-desist from the University of Michigan's general counsel and president demanding he hand it over for free. Cuban refused, kept the domain, and now tells the story on every podcast he can. "I'm going to take advantage of it and get more than my $38,000 worth," he said. It's a small window into how he operates: use leverage, don't back down, and treat opacity as an attack to be countered with transparency.

How Drug Prices Actually Dropped—and What Didn't Cause It

When prescription drug prices posted their biggest year-over-year drop in more than sixty years, both the Trump and Biden camps claimed credit. Cuban, whose company Cost Plus Drugs partners with the TrumpRX.com portal, gave a more grounded explanation. TrumpRX refers traffic—people search for a drug, and if Cost Plus is the cheapest option, they get sent there. Since the portal launched, Cuban says Cost Plus has dropped prices on over 200 medications because higher volume drives down their own costs, and they pass those savings through at a fixed 15% markup.